Improving genetic testing for kidney disease in diverse communities
Advancing equitable implementation of genomic medicine in nephrology
This study is looking to make genetic testing more accessible for kidney disease patients, especially those from underrepresented backgrounds, by finding out what gets in the way and creating helpful tools and guidelines for both patients and doctors.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10906807 on NIH RePORTER |
What this research studies
This research aims to enhance the use of genetic testing in nephrology, particularly among patients from marginalized racial and ethnic backgrounds. It will identify barriers that prevent nephrologists and patients from utilizing genetic testing, which can help personalize treatment for kidney diseases. The study will involve collecting data through various methods and developing tools to support both patients and healthcare providers in understanding and implementing genetic testing. The goal is to create guidelines that facilitate the integration of genetic testing into standard nephrology care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with chronic kidney disease, especially those from marginalized racial and ethnic groups.
Not a fit: Patients who do not have chronic kidney disease or those who are not interested in genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for kidney disease, particularly for underrepresented populations.
How similar studies have performed: Other research has shown success in implementing genetic testing in various medical fields, indicating that this approach has potential for positive outcomes in nephrology as well.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Milo Rasouly, Hila — Columbia University Health Sciences
- Study coordinator: Milo Rasouly, Hila
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.